Pfizer Inc. and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the U.S. drugmaker.
from CBC | Health News https://ift.tt/35m98aW
Aucun commentaire:
Enregistrer un commentaire